SCHEMBL4295065

SCHEMBL4295065

CC(C)C(N)(CCOCn1cnc2c(=O)nc(N)[nH]c21)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
HBB P68871 2/20 0.44
MAPK1 P28482 1/20 0.44
PNP P00491 8/20 0.43
BLM P54132 2/20 0.43
USP2 O75604 1/20 0.43
TSHR P16473 1/20 0.43
EDNRA P25101 1/20 0.43
HTR2A P28223 1/20 0.43
RECQL P46063 1/20 0.43
HSD17B10 Q99714 1/20 0.43
HPRT1 P00492 4/20 0.40
POLG P54098 1/20 0.38
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
CYP3A4 P08684 1/20 0.36
NFKB1 P19838 1/20 0.36
VCP P55072 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15655101 1.00 MEN1 (0.45) MEN1KMT2AHBBMAPK1PNP
SCHEMBL16037211 0.82 PNP (0.43) MEN1KMT2AHBBMAPK1PNP
SCHEMBL4295062 0.80 KMT2A (0.41) MEN1KMT2AHBBMAPK1PNP
SCHEMBL15655099 0.80 KMT2A (0.41) MEN1KMT2AHBBMAPK1PNP
Acyclovir SCHEMBL40723 0.79 PNP (0.67) MEN1KMT2AHBBMAPK1PNP
SCHEMBL23948433 0.78 KMT2A (0.53) MEN1KMT2AHBBMAPK1PNP
Valacyclovir SCHEMBL34375 0.78 KMT2A (0.72) MEN1KMT2AHBBMAPK1PNP
Valacyclovir SCHEMBL4295083 0.78 KMT2A (0.72) MEN1KMT2AHBBMAPK1PNP
SCHEMBL4295075 0.78 KMT2A (0.48) MEN1KMT2AHBBMAPK1PNP
Valacyclovir SCHEMBL29689659 0.77 HBB (0.72) MEN1KMT2AHBBMAPK1PNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200046715-A1 Medicament for Treating Peripheral Neuropathies HSIAO LILY (TW) 2020-02-13 US claimed
US-10471064-B2 Medicament for treating peripheral neuropathies Hsiao, Lily (TW) 2019-11-12 US claimed
US-20180193348-A1 Medicament for Treating Peripheral Neuropathies HSIAO LILY (TW) 2018-07-12 US claimed
US-20170056408-A1 MEDICAMENT FOR TREATING PERIPHERAL NEUROPATHIES YU HSIAO LILY (JP) 2017-03-02 US claimed
US-9526729-B2 Medicament for treating peripheral neuropathies Yu, Hsiao Lily (JP) 2016-12-27 US claimed
US-20150238493-A1 MEDICAMENT FOR TREATING PERIPHERAL NEUROPATHIES YU HSIAO LILY (JP) 2015-08-27 US claimed
US-20140213600-A1 MEDICAMENT FOR TREATING PERIPHERAL NEUROPATHIES HSIAO LILY (TW) 2014-07-31 US claimed
CN-114306596-A Topical application of anti-HSV antibodies 海德堡免疫疗法有限公司 2022-04-12 CN disclosed
CN-106488931-B Topical application of anti-HSV antibodies 海德堡免疫疗法有限公司 2021-12-28 CN disclosed
US-20200046715-A1 Medicament for Treating Peripheral Neuropathies HSIAO LILY (TW) 2020-02-13 US disclosed
US-20200046715-A1 Medicament for Treating Peripheral Neuropathies HSIAO LILY (TW) 2020-02-13 US disclosed
US-10471064-B2 Medicament for treating peripheral neuropathies Hsiao, Lily (TW) 2019-11-12 US disclosed
US-10471064-B2 Medicament for treating peripheral neuropathies Hsiao, Lily (TW) 2019-11-12 US disclosed
US-20180193348-A1 Medicament for Treating Peripheral Neuropathies HSIAO LILY (TW) 2018-07-12 US disclosed
US-20170056408-A1 MEDICAMENT FOR TREATING PERIPHERAL NEUROPATHIES YU HSIAO LILY (JP) 2017-03-02 US disclosed
US-9526729-B2 Medicament for treating peripheral neuropathies Yu, Hsiao Lily (JP) 2016-12-27 US disclosed
US-20150238493-A1 MEDICAMENT FOR TREATING PERIPHERAL NEUROPATHIES YU HSIAO LILY (JP) 2015-08-27 US disclosed
US-20140213600-A1 MEDICAMENT FOR TREATING PERIPHERAL NEUROPATHIES HSIAO LILY (TW) 2014-07-31 US disclosed
WO-2009129094-A2 COMPOSITIONS CONTAINING ANTIVIRAL COMPOUNDS AND METHODS OF USING THE SAME MALLINCKRODT INC. (US) 2009-10-22 WO disclosed
US-20090258843-A1 Compositions Containing Antiviral Compounds and Methods of Using the Same MALLINCKRODT INC. (US) 2009-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258843-A1 Compositions Containing Antiviral Compounds and Methods of Using the Same EIF2AK2, MAVS, IRF3 MEN1 3203/4885KMT2A 3346/4885HBB 3885/4885
US-20140213600-A1 MEDICAMENT FOR TREATING PERIPHERAL NEUROPATHIES PMP22, DPM1, SUCLG1 MEN1 632/4885KMT2A 1711/4885HBB 2084/4885
US-10471064-B2 Medicament for treating peripheral neuropathies NGF, TSLP, BDNF MEN1 4356/4885KMT2A 920/4885HBB 4273/4885
US-20200046715-A1 Medicament for Treating Peripheral Neuropathies NGF, PMP22, BPGM MEN1 3466/4885KMT2A 1810/4885HBB 2477/4885
US-20180193348-A1 Medicament for Treating Peripheral Neuropathies NGF, TSLP, BDNF MEN1 4356/4885KMT2A 920/4885HBB 4273/4885
US-20170056408-A1 MEDICAMENT FOR TREATING PERIPHERAL NEUROPATHIES PMP22, SNCA, PARL MEN1 1309/4885KMT2A 1917/4885HBB 1450/4885
US-20150238493-A1 MEDICAMENT FOR TREATING PERIPHERAL NEUROPATHIES PMP22, SNCA, PARL MEN1 1309/4885KMT2A 1917/4885HBB 1450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.